The main theme of the report is the return on investment (ROI) from the use of artificial intelligence (AI) in healthcare and life sciences.
The report highlights how AI agents help improve patient outcomes and how companies are moving from planning to action, using AI for growth, reducing operational costs, and mitigating critical risks. It notes that nearly half of executives are already using AI agents and that there is a range of complex AI use cases.